Position in ABSI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$41,528,858
+$31,499,654 QoQ
Shares Held
3,583,163
+7.2% QoQ
Ownership
2.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 195 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. ABSI ranks #95 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ABSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,528,858 | 3,583,163 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $10,029,204 | 3,343,068 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $11,306,283 | 3,239,623 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $9,280,860 | 3,052,915 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,284,805 | 2,445,450 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,011,129 | 1,996,466 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,108,501 | 1,949,810 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,386,325 | 1,933,593 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $5,573,865 | 1,809,697 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,897,383 | 686,159 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,783,260 | 662,681 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $751,301 | 569,168 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $683,119 | 449,421 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,595,279 | 911,588 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,989,678 | 947,466 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,963,105 | 946,679 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,177,783 | 655,959 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,368,046 | 636,779 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,332,506 | 284,452 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,249,183 | 193,395 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||